Jacob joined the Company in 2017 and oversees business development, fundraising and day-to-day Company operations at VLP Therapeutics. He is a seasoned business development and strategy executive with nearly 20 years of industry experience.
Prior to VLP, he spent 10½ years at Emergent BioSolutions, an NYSE-listed specialty pharmaceuticals company, most recently as Vice President, Corporate Development. At Emergent, Jacob led strategic planning and initiated, executed and integrated several acquisitions and strategic collaborations valued at more than $400 million.
Prior to Emergent, Jacob served in a business development role at GenVec, a gene therapy company; at Monsanto Corporation where he focused on corporate strategy and business development in the pharmaceutical and agricultural biotechnology businesses; and at a boutique contract research organization focused on CNS drug development. Jacob holds a BA from the University of Chicago and an MBA from the Olin Business School at Washington University in St. Louis.